HK Stock MarketDetailed Quotes
08037 CH BIOTECH SER
- 0.440
- 0.0000.00%
Trading Nov 28 09:01 CST
429.32MMarket Cap-2972P/E (TTM)
0.000High0.000Low0Volume0.000Open0.440Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)975.73MShares0.80052wk High1.10P/B429.32MFloat Cap0.25052wk Low--Dividend TTM975.73MShs Float3.985Historical High--Dividend LFY0.00%Amplitude0.114Historical Low--Avg Price5000Lot Size--Div YieldTTM--Div Yield LFY
CH BIOTECH SER Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -116.46%-142.03M | ---- | 377.58%862.83M | ---- | -10.91%180.67M | ---- | 285.05%202.8M | ---- | -58.27%-109.59M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -2,345.75%-3.74M | ---- | -1,175.00%-153K | ---- | 42.86%-12K | ---- | 88.89%-21K | ---- | -845.00%-189K |
| Dividend (income)- adjustment | ---- | ---23K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 83.68%7.68M | ---- | --4.18M | ---- | ---- | ---- | ---- | ---- | 202.17%1.39M |
| Impairment and provisions: | ---- | 961.17%36.4M | ---- | -0.58%3.43M | ---- | 175.56%3.45M | ---- | -96.54%1.25M | ---- | 921.46%36.18M |
| -Impairment of property, plant and equipment (reversal) | ---- | --16.19M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | --11.67M | ---- | ---- | ---- | 2,889.72%3.2M | ---- | -40.22%107K | ---- | 198.35%179K |
| -Impairment of goodwill | ---- | ---- | ---- | --1.72M | ---- | ---- | ---- | ---- | ---- | --264K |
| -Other impairments and provisions | ---- | 398.31%8.54M | ---- | 582.87%1.71M | ---- | -78.08%251K | ---- | -96.80%1.15M | ---- | 859.64%35.74M |
| Revaluation surplus: | ---- | 27.32%-18.34M | ---- | -3,458.25%-25.23M | ---- | 94.01%-709K | ---- | 20.50%-11.83M | ---- | -3,848.61%-14.88M |
| -Derivative financial instruments fair value (increase) | ---- | -1,712.66%-18.34M | ---- | -40.81%1.14M | ---- | 130.09%1.92M | ---- | ---6.38M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -902.47%-26.37M | ---- | 51.72%-2.63M | ---- | 63.40%-5.45M | ---- | -3,848.61%-14.88M |
| Asset sale loss (gain): | ---- | 89.42%-294K | ---- | ---2.78M | ---- | ---- | ---- | 1,011.47%1.99M | ---- | 96.36%-218K |
| -Loss (gain) from sale of subsidiary company | ---- | 101.53%26K | ---- | ---1.7M | ---- | ---- | ---- | 516.46%1.95M | ---- | 107.44%316K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 70.24%-322K | ---- | ---1.08M | ---- | ---- | ---- | 107.30%39K | ---- | 69.22%-534K |
| -Loss (gain) from selling other assets | ---- | --2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -16.30%55.58M | ---- | -2.51%66.4M | ---- | 68.86%68.11M | ---- | 99.67%40.34M | ---- | 138.08%20.2M |
| -Amortization of intangible assets | ---- | -5.08%8.25M | ---- | -3.39%8.69M | ---- | 7.17%8.99M | ---- | 8.20%8.39M | ---- | 533.14%7.76M |
| Financial expense | ---- | 51.96%5.31M | ---- | -46.58%3.5M | ---- | 0.69%6.54M | ---- | 284.04%6.5M | ---- | -51.27%1.69M |
| Special items | ---- | -41.74%3.34M | ---- | -27.72%5.73M | ---- | -13.07%7.92M | ---- | -27.01%9.11M | ---- | 1.27%12.49M |
| Operating profit before the change of operating capital | ---- | -106.11%-56.12M | ---- | 245.11%917.9M | ---- | 6.33%265.97M | ---- | 572.55%250.14M | ---- | -13.68%-52.93M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 84.13%-2.22M | ---- | -481.58%-13.99M | ---- | 4.41%-2.41M | ---- | -2,087.83%-2.52M | ---- | 78.22%-115K |
| Accounts receivable (increase)decrease | ---- | 209.67%728.45M | ---- | -923.12%-664.23M | ---- | -193.43%-64.92M | ---- | -239.48%-22.13M | ---- | -56.08%15.86M |
| Accounts payable increase (decrease) | ---- | -198.22%-232.89M | ---- | 249.81%237.1M | ---- | -180.19%-158.27M | ---- | 9,076.24%197.38M | ---- | -68.11%2.15M |
| Special items for working capital changes | ---- | -81.55%1.44M | ---- | 11,379.41%7.81M | ---- | 168.00%68K | ---- | -102.10%-100K | ---- | 151.33%4.76M |
| Cash from business operations | ---- | -9.48%438.66M | ---- | 1,098.15%484.59M | ---- | -90.43%40.45M | ---- | 1,496.45%422.78M | ---- | -124.16%-30.28M |
| Other taxs | ---- | -13,117.32%-243.46M | ---- | -3,170.00%-1.84M | ---- | 107.72%60K | ---- | -2,406.45%-777K | ---- | 97.53%-31K |
| Special items of business | -130.73%-95.54M | ---- | 68.92%310.86M | ---- | 663.68%184.03M | ---- | 12.07%-32.65M | ---- | -117.41%-37.13M | ---- |
| Net cash from operations | -130.73%-95.54M | -59.57%195.19M | 68.92%310.86M | 1,091.82%482.75M | 663.68%184.03M | -90.40%40.51M | 12.07%-32.65M | 1,492.46%422M | -117.41%-37.13M | -105.34%-30.31M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 2,345.75%3.74M | ---- | 1,175.00%153K | ---- | -42.86%12K | ---- | -88.89%21K | ---- | 845.00%189K |
| Dividend received - investment | ---- | --23K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | 95.14%-6.25M | ---- | ---128.56M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | 1,027.27%372K | ---- | --33K | ---- | ---- | ---- | -74.75%202K | ---- | -83.84%800K |
| Purchase of fixed assets | ---- | -5.33%-59.41M | ---- | -361.72%-56.4M | ---- | 90.35%-12.22M | ---- | -1,622.21%-126.6M | ---- | -13.16%-7.35M |
| Purchase of intangible assets | ---- | ---- | ---- | ---13.35M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | 32.14%7.1M | ---- | --5.37M | ---- | ---- | ---- | 706.25%129K | ---- | -99.23%16K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.41M |
| Cash on investment | ---- | 94.55%-3.47M | ---- | ---63.63M | ---- | ---- | ---- | ---- | ---- | -117.62%-85.48M |
| Other items in the investment business | 57.53%-61.47M | -14,059.42%-9.63M | -18.06%-144.74M | -98.31%69K | 27.36%-122.6M | --4.08M | -18,488.66%-168.79M | ---- | 98.74%-908K | ---- |
| Net cash from investment operations | 57.53%-61.47M | 73.65%-67.53M | -18.06%-144.74M | -3,054.99%-256.31M | 27.36%-122.6M | 93.57%-8.12M | -18,488.66%-168.79M | -25.95%-126.25M | 98.74%-908K | -174.36%-100.24M |
| Net cash before financing | -194.52%-157.01M | -43.62%127.66M | 170.44%166.12M | 599.29%226.44M | 130.49%61.43M | -89.05%32.38M | -429.57%-201.43M | 326.55%295.75M | 57.42%-38.04M | -154.50%-130.54M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 662.04%31.05M | ---- | -81.73%4.08M | ---- | 116.93%22.3M | ---- | -57.11%10.28M | ---- | 137.61%23.97M |
| Refund | ---- | ---- | ---- | 32.38%-8.15M | ---- | 49.64%-12.05M | ---- | -322.23%-23.94M | ---- | -6.76%-5.67M |
| Issuing shares | ---- | ---- | ---- | --38.98M | ---- | ---- | ---- | 558.50%76.39M | ---- | -91.22%11.6M |
| Interest paid - financing | ---- | -66.76%-6.39M | ---- | -16.27%-3.83M | ---- | 42.48%-3.29M | ---- | -252.87%-5.73M | ---- | 51.71%-1.62M |
| Dividends paid - financing | ---- | 48.00%-156M | ---- | -38.89%-300M | ---- | ---216M | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | 0.00%490K | ---- | -74.69%490K | ---- | -0.72%1.94M | ---- | --1.95M |
| Issuance expenses and redemption of securities expenses | ---- | -21.84%-3.64M | ---- | 93.29%-2.99M | ---- | -887.07%-44.5M | ---- | -785.66%-4.51M | ---- | 41.76%-509K |
| Other items of the financing business | 1,194.21%118.56M | ---- | -51.24%-10.84M | ---- | 85.73%-7.16M | ---- | -196.15%-50.21M | ---- | 497.16%52.22M | ---- |
| Net cash from financing operations | 1,194.21%118.56M | 48.16%-146.17M | -51.24%-10.84M | -5.76%-281.96M | 85.73%-7.16M | -706.80%-266.61M | -196.15%-50.21M | 90.42%43.94M | 497.16%52.22M | -82.60%23.07M |
| Effect of rate | 85.06%-397K | 3.71%-2.18M | -3,950.72%-2.66M | -1,023.27%-2.26M | -74.06%69K | 136.73%245K | 279.73%266K | 55.29%-667K | 84.37%-148K | -3,290.91%-1.49M |
| Net Cash | -124.76%-38.45M | 66.67%-18.51M | 186.18%155.28M | 76.30%-55.52M | 121.56%54.26M | -168.95%-234.23M | -1,874.72%-251.64M | 416.08%339.69M | 117.59%14.18M | -232.12%-107.47M |
| Begining period cash | -22.29%72.09M | -38.38%92.77M | -38.38%92.77M | -60.85%150.55M | -60.85%150.55M | 744.81%384.54M | 744.81%384.54M | -70.53%45.52M | -70.53%45.52M | 111.09%154.48M |
| Cash at the end | -86.45%33.24M | -22.29%72.09M | 19.77%245.4M | -38.38%92.77M | 53.85%204.88M | -60.85%150.55M | 123.63%133.17M | 744.81%384.54M | -18.36%59.55M | -70.53%45.52M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data